Effects of novel synthetic serine protease inhibitors on postoperative blood loss, coagulation parameters, and vascular relaxation after cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 1, 2010, Pages 181-188

  Szabó, Gábor ^a   Veres, Gábor ^a   Radovits, Tamás ^a   Haider, Humaira ^a   Krieger, Nelli ^a   Bährle, Susanne ^b   Miesel Gröschel, Christiane ^a   Niklisch, Silke ^c   Karck, Matthias ^a   van de Locht, Andreas ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c Curacyte Discovery GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIFIBRINOLYTIC AGENT; APROTININ; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 12A; CU 2010; CU 2020; NITROPRUSSIDE SODIUM; PLASMA KALLIKREIN; PLASMIN; PROTAMINE; SERINE PROTEINASE INHIBITOR; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CONTINUOUS INFUSION; DOG; DRUG EFFECT; HEART SURGERY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; VASODILATATION;

ANIMALS; APROTININ; BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DOGS; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; SERINE PROTEINASE INHIBITORS; VASODILATION;

EID: 73149106987     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.09.019     Document Type: Article

References (23)

1. Dacey L.J., Munoz J.J., Baribeau Y.R., Johnson E.R., Lahey S.J., Leavitt B.J., et al. Reexploration for hemorrhage following coronary artery bypass grafting. Arch Surg 133 (1998) 442-447
2. Keogh B., and Kinsman R. Fifth national adult cardiac surgical database report 2003. Reading (UK): Dendrite Clinical Systems (2004)
3. Beierlein W., Scheule A.M., Dietrich W., and Ziemer G. Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann Thorac Surg 79 (2005) 741-748
4. Dietrich W., Spath P., Zuhlsdorf M., Dalichau H., Kirchhoff P.G., Kuppe H., et al. Anaphylactic reactions to aprotinin reexposure in cardiac surgery: relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology 95 (2001) 64-71
5. Katz B.A., Sprengeler P.A., Luong C., Verner E., Elrod K., Kirtley M., et al. Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets. Chem Biol 8 (2001) 1107-1121
6. Alderman E.L., Levy J.H., Rich J.B., Nili M., Vidne B., Schaff H., et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 116 (1998) 716-730
7. Kalkat A., Levine, and Dunning J. Does use of aprotinin in coronary artery bypass graft surgery affect graft patency?. Interact Cardiovasc Thorac Surg 3 (2004) 124-128
8. Bidstrup B.P., Underwood S.R., Sapsford R.N., and Streets R.M. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency. J Thorac Cardiovasc Surg 105 (1993) 147-152
9. Khan T.A., Bianchi C., Voisine O., Feng J., Baker J., Hart M., et al. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg 128 (2004) 602-608
10. Ülker S., Cinar M.G., Bayraktutan U., and Evinc A. Aprotinin impairs endothelium-dependent relaxation in rat aorta and inhibits nitric oxide release from rat coronary endothelial cells. Cardiovasc Res 50 (2001) 589-596
11. Ülker S., McKeown P.P., and Bayraktutan U. Aprotinin impairs coronary endothelial function and down-regulates endothelial NOS in rat coronary microvascular endothelial cells. Cardiovasc Res 55 (2002) 830-837
12. Blauhut B., Gross C., Necek S., Doran J.E., Spath P., and Lundsgaard-Hansen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 101 (1991) 958-967
13. Royston D., Bidstrup B.P., Taylor K.M., and Sapsford R.N. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2 (1987) 1289-1291
14. Murkin J.M., Lux J., Shannon N.A., Guiraudon G.M., Menkis A.H., McKenzie F.N., et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 107 (1994) 554-561
15. Bittner H.B., Lamke J., Lange M., Rastan A., and Mohr F.W. The impact of aprotinin on blood loss and blood transfusion in off pump coronary artery bypass grafting. Ann Thorac Surg 85 (2008) 1662-1668
16. Dietrich W., Nicklisch S., Koster A., Spannagl M., Giersiefen H., and van de Locht A. CU-2010-a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties. Anesthesiology 110 (2009) 123-130
17. Landis R.C., Asimakopoulos G., Poullis M., Haskard D.O., and Taylor K.M. The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg 72 (2001) 2169-2175
18. Khan T.A., Bianchi C., Voisine P., Sandmeyer J., Feng J., and Sellke F.W. Aprotinin inhibits protease-dependent platelet aggregation and thrombosis. Ann Thorac Surg 79 (2005) 1545-1550
19. Despotis G.J., Filos K.S., Levine V., Alsoufiev A., and Spitznagel E. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro. Anesth Analg 82 (1996) 1126-1131
20. Wang J.S., Lin C.Y., Hung W.T., Thisted R.A., and Karp R.B. In vitro effects of aprotinin on activated clotting time measured with different activators. J Thorac Cardiovasc Surg 104 (1992) 1135-1140
21. Veres G., Radovits T., Schulz H., Linn L.N., Hütter J., Weigang E., et al. Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass. Eur J Cardiothorac Surg 28 (2007) 801-804
22. Fischer J.H., and Steinhoff M. Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries. Eur J Cardiothorac Surg 28 (2005) 801-804
23. Allen S., Anastasiou N., Royston D., Paniagua R., and Yacoub M. Effect of aprotinin on vascular reactivity of coronary bypass grafts. J Thorac Cardiovasc Surg 113 (1997) 319-326